Valuation: Hypera S.A.

Market Cap 1.56TCr 278.38Cr 249.65Cr 230.08Cr 208.95Cr 395.45Cr 26TCr 406.49Cr 2.75TCr 1.1TCr 14TCr 1.04TCr 1.02TCr 44TCr P/E 2026 *
8.2x
P/E 2027 * 7.3x
Enterprise Value 2.18TCr 388.23Cr 348.16Cr 320.87Cr 291.4Cr 551.5Cr 36TCr 566.89Cr 3.84TCr 1.53TCr 20TCr 1.46TCr 1.43TCr 62TCr EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.03x
Free-Float
43.25%
Yield 2026 *
5.55%
Yield 2027 * 4.89%
1 day-2.56%
1 week+4.44%
Current month+2.83%
1 month-24.53%
3 months-6.76%
6 months-17.61%
Current year-3.32%
1 week 3.88
Extreme 3.88
4.15
1 month 3.39
Extreme 3.39
5.46
Current year 3.39
Extreme 3.39
5.77
1 year 3.39
Extreme 3.39
5.77
3 years 2.64
Extreme 2.64
7.9
5 years 2.64
Extreme 2.64
10.08
10 years 2.64
Extreme 2.64
11.98
Manager TitleAgeSince
Chief Executive Officer 51 24/04/2019
Director of Finance/CFO 39 24/02/2022
Chief Operating Officer 41 01/01/2020
Director TitleAgeSince
Director/Board Member 77 01/06/2007
Director/Board Member 60 01/06/2007
Director/Board Member 52 26/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%+4.44% - - 286.72Cr
+1.44%+1.63%+48.17%+139.63% 1,25800Cr
-0.47%+5.49%+49.03%+90.68% 68TCr
+0.20%+2.76%+34.37%+112.06% 52TCr
+0.17%+2.76%+44.07%+69.71% 39TCr
-0.48%+2.34%+70.66%+46.02% 37TCr
+0.76%+2.27%+31.59%+60.36% 31TCr
-1.29%+0.90%+5.77%+37.60% 29TCr
0.00%+0.86%+43.74%+74.04% 25TCr
+0.92%+2.03%+44.62%+125.07% 21TCr
Average -0.28%+1.05%+41.34%+83.91% 47TCr
Weighted average by Cap. -0.09%+1.18%+43.66%+96.83%

Financials

2026 *2027 *
Net sales 924.21Cr 164.84Cr 147.83Cr 136.24Cr 123.73Cr 234.17Cr 15TCr 240.7Cr 1.63TCr 649.94Cr 8.28TCr 618.64Cr 605.52Cr 26TCr 1.03TCr 183.97Cr 164.98Cr 152.05Cr 138.08Cr 261.33Cr 17TCr 268.63Cr 1.82TCr 725.35Cr 9.24TCr 690.41Cr 675.77Cr 29TCr
Net income 188.68Cr 34Cr 30Cr 28Cr 25Cr 48Cr 3.16TCr 49Cr 333.04Cr 132.69Cr 1.69TCr 126.3Cr 123.62Cr 5.34TCr 217.89Cr 39Cr 35Cr 32Cr 29Cr 55Cr 3.64TCr 57Cr 384.59Cr 153.23Cr 1.95TCr 145.85Cr 142.76Cr 6.17TCr
Net Debt 615.89Cr 109.85Cr 99Cr 91Cr 82Cr 156.05Cr 10TCr 160.4Cr 1.09TCr 433.12Cr 5.52TCr 412.26Cr 403.52Cr 17TCr 530.31Cr 95Cr 85Cr 78Cr 71Cr 134.37Cr 8.87TCr 138.12Cr 936.03Cr 372.94Cr 4.75TCr 354.98Cr 347.45Cr 15TCr
Projected Income Statement - Annual - Hypera S.A.
Logo Hypera S.A.
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription medicines; - branded generic medicines.
Employees
10,564
Date Price Change Volume
10/26/10 $4.000 -2.56% 38,771
09/26/09 $4.105 +2.11% 88,455
06/26/06 $4.020 +2.55% 87,591
05/26/05 $3.920 +0.51% 18,508
04/26/04 $3.900 +1.83% 12,621
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Hypera S.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
22.17BRL
Average target price
30.18BRL
Spread / Average Target
+36.14%